Sophia Genetics SA (NAS:SOPH)
$ 7.67 -0.010 (-0.13%) Market Cap: 643.48 Mil Enterprise Value: 597.64 Mil PE Ratio: 0 PB Ratio: 6.79 GF Score: 70/100

Q1 2026 SOPHiA GENETICS SA Earnings Call Transcript

May 05, 2026 / 12:00PM GMT
Release Date Price: $5.07 (-4.16%)
Operator

Good morning. My name is Vincent, and I'll be your conference operator today. At this time, I would like to welcome everyone to the SOPHiA GENETICS First Quarter 2026 Earnings Conference Call.

(Operator Instructions).

Kellen Sanger, SOPHiA GENETICS VP of Strategy.

Begin.

Kellen Sanger
SOPHiA GENETICS SA - VP, Head of Strategy

Thank you, and good morning, everyone. Welcome to the SOPHiA GENETICS First Quarter 2026 Earnings Conference Call. Joining me today to discuss our results are Dr. Jurgi Camblong, our Co-Founder and Chief Executive Officer; Ross Muken, our Company President, and George Cardoza, our Chief Financial Officer.

I'd like to remind you that management will make statements during this call that are forward-looking statements within the meanings of federal securities laws. These statements involve material risks and uncertainties. That could cause actual results or events to materially differ from those anticipated, and you should not place undue reliance on forward-looking statements.

Additional

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot